Reuters logo
BRIEF-Zealand Pharma completes Patient recruitment for phase II trial with glepaglutide
February 6, 2017 / 2:31 PM / 8 months ago

BRIEF-Zealand Pharma completes Patient recruitment for phase II trial with glepaglutide

Feb 6 (Reuters) - Zealand Pharma A/S

* Patient recruitment completed for phase II trial with glepaglutide for treatment of short bowel syndrome

* Results of phase II trial are expected mid 2017 Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below